Series A  ·  €5–7M  ·  2026

The operating system drug discovery never had.

We went to the labs. We sat with the scientists. We asked the world's leading pharmaceutical companies what they actually needed. Then we built it.

11/20
Top global pharma
~€3M
Revenue 2025
Q4 '25
Profitable

Scroll to see the platform

The platform

One place. Every layer of the stack.

An AI operating system that connects the physical and digital worlds of drug discovery — automated wet labs, biological data, and intelligent decision-making, unified for the first time.

⬡
Planner
Biological workflows, timelines and team progress in one collaborative workspace
◈
Inventory
Every cell model, reagent and sample tracked, searchable and always current
◎
Discovery
Order, schedule and run high-throughput imaging campaigns directly from the platform
⬡
Tox
Clinical readouts, chemical structures and phenomics screenings unified — now expanding into cardiotoxicity and transcriptomics
✦
Alchemist
Agentic AI layer — query, analyse, schedule and decide across your entire biology stack

The OS

One entry point. Every system.

The pixlbio portal is the unified front door — every module accessible from a single workspace. Projects, biology, data, AI. No context switching, no handoffs.

pixlbio OS portal

Inventory

The lab, fully in view.

Every vial, cryopreserved cell, compound and reagent — tracked in real time, across sites. Barcoded, searchable, always current. The LIMS your researchers will actually use.

Inventory dashboard

Discovery

Imaging at scale. Analytics on demand.

32 active projects. 673 plates. Workflows dispatched and completed automatically. Data captures feed straight into analysis pipelines — no manual handoffs, no waiting.

Discovery dashboard

Tox Suite

The first system that unifies what has always been kept apart.

Built not because we thought it was a good idea — but because our customers told us their pipelines were failing without it.

Clinical readouts Chemical structures Functional screenings Phenomics Transcriptomics ↗ Cardiotoxicity ↗
Tox DILIrank dashboard

Alchemist

Not for today's AI wave. For what comes next.

Autonomous agents that query your data, check your inventory, schedule your screenings and surface ADMET risk — all through natural language. Built for the agentic era, running today.

Alchemist project and task query

01 — Project and task status across sites

Alchemist inventory BOM check

02 — Live inventory and protocol readiness

Alchemist DILI risk profiling

03 — ADMET and DILI risk profiling on demand

The moat

The barrier to entry isn't code. It's credibility.

Pharma doesn't hand their most sensitive workflows to a team that has never run a screen, never worked with iPSC-derived cell models, never understood why a morphological readout matters more than a viability number.

Years of that credibility, built inside the most demanding R&D environments in the world. That's why they let us in — and why we're embedded in workflows that don't get ripped out.

Series A — €5–7M

The OS launches soon. Investors who move now get in before the world finds out.

Reply and we'll set up a 20-minute walkthrough of the platform. No deck. No pitch. Just the real thing.

christopher.trummer@pixl.bio

This page is for prospective investors only